Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancer

Chinese Science Bulletin

Volumn 55, Issue 31, 2010, Pages 3576-3589

  Yang, Xi Nan ^a,b   Lee, Younghee ^b   Fan, Hong ^a   Sun, Xiao ^a   Lussier, Yves A ^b,c,d  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c University of Chicago   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

biomodule; cancer; gene expression; microRNA expression; molecular diagnosis

Indexed keywords

EID: 78349303386     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-010-4051-1     Document Type: Article

References (88)

1. Rhodes D R, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA, 2004, 101: 9309-9314.
2. Segal E, Friedman N, Koller D, et al. A module map showing conditional activity of expression modules in cancer. Nat Genet, 2004, 36: 1090-1098.
3. Yang X, Bentink S, Spang R. Detecting common gene expression patterns in multiple cancer outcome entities. Biomed Microdevices, 2005, 7: 247-251.
4. Volinia S, Calin G A, Liu C G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 2006, 103: 2257-2261.
5. Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 2002. 99: 15524-15529.
6. Calin G A, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 2005, 353: 1793-1801.
7. Iorio M V, Ferracin M, Liu C G, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 2005, 65: 7065-7070.
8. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9: 189-198.
9. Ruike Y, Ichimura A, Tsuchiya S, et al. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet, 2008, 53: 515-523.
10. Ambs S, Prueitt RL, Yi M, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res, 2008, 68: 6162-6170.
11. Pasquinelli A E, Reinhart B J, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 2000, 408: 86-89.
12. John B, Enright A J, Aravin A, et al. Human microRNA targets. PLoS Biol, 2004, 2: e363.
13. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838.
14. Griffiths-Jones S. miRBase: The microRNA sequence database. Methods Mol Biol, 2006, 342: 129-138.
15. Griffiths-Jones S, Saini H K, van Dongen S, et al. miRBase: Tools for microRNA genomics. Nucleic Acids Res, 2008, 36(Database issue): D154-158.
16. Yang Y, Wang Y P, Li K B. miRTif: A support vector machine-based microRNA target interaction filter. BMC Bioinformatics, 2008, 9 (Suppl 12): S4.
17. Chen K, Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet, 2006, 38: 1452-1456.
18. Sethupathy P, Corda B, Hatzigeorgiou A G. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA, 2006, 12: 192-197.
19. Grimson A, Farh K K, Johnston W K, et al. microRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell, 2007, 27: 91-105.
20. Bartel D P. microRNAs: Target recognition and regulatory functions. Cell, 2009, 136: 215-233.
21. Sethupathy P, Megraw M, Hatzigeorgiou A G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods, 2006, 3: 881-886.
22. Lewis B P, Shih I H, Jones-Rhoades M W, et al. Prediction of mammalian microRNA targets. Cell, 2003 115: 787-798.
23. Lanza G, Ferracin M, Gafa R, et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer, 2007, 6: 54.
24. Joung J G, Hwang K B, Nam J W, et al. Discovery of microRNA-mRNA modules via population-based probabilistic learning. Bioinformatics, 2007, 23: 1141-1147.
25. Liu B, Li J, Tsykin A. Discovery of functional miRNA-mRNA regulatory modules with computational methods. J Biomed Infor, 2009, 42: 685-691.
26. Tran D H, Satou K, Ho T B. Finding microRNA regulatory modules in human genome using rule induction. BMC Bioinform, 2008, 9(Suppl 12): S5.
27. Xin F, Li M, Balch C, et al. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics, 2009, 25: 430-434.
28. Gennarino V A, Sardiello M, Avellino R, et al. microRNA target prediction by expression analysis of host genes. Genome Res, 2009, 19: 481-490.
29. Tsang J, Zhu J, van Oudenaarden A. microRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell, 2007, 26: 753-767.
30. O'Donnell K A, Wentzel E A, Zeller K I, et al. c-Myc-regulated microRNAs modulate E2F1 expression Nature, 2005, 435: 839-843.
31. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA, 2001, 98: 15149-15154.
32. Zhu J, Hastie T. Classification of gene microarrays by penalized logistic regression. Biostatistics, 2004, 5: 427-443.
33. Shen L, Tan E C. Dimension reduction-based penalized logistic regression for cancer classification using microarray data. IEEE/ACM Trans Comput Biol Bioinform, 2005, 2: 166-175.
34. Yu X, Lin J, Zack D J, et al. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res, 2008, 36: 6494-6503.
35. Reimers M, Carey V J. Bioconductor: An open source framework for bioinformatics and computational biology. Methods Enzymol, 2006, 411: 119-134.
36. Wang Y, Dunham M H, Waddle J A, et al. Classification for poorly differentiated tumor classification using both messenger rna and microrna expression profiles. In: 2006 Computational Systems Bioinformatics Conference (CSB 2006) 2006: Stanford, California.
37. Dettling M, Buhlmann P. Finding predictive gene groups from microarray data. J Mult Anal, 2004, 90: 106-131.
38. Cessie S L, Houwelingen J V. Ridge estimators in logistic regression. Appl Stat, 1990, 41: 191-201.
39. Alzola C, Harrell F. An Introduction to S and the Hmisc and Design Libraries, Nov 16, 2004. http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/RS/sintroPDF.
40. Dettling M, Buhlmann P. Supervised clustering of genes. Genome Biol, 2002, 3: RESEARCH0069.
41. Huang J C, Morris Q D, Frey B J. Bayesian inference of microRNA targets from sequence and expression data. J Comput Biol, 2007, 14: 550-563.
42. Baskerville S, Bartel D P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 2005, 11: 241-247.
43. Dudoit S, Fridlyand J, Speed T. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc, 2002, 97: 77-87.
44. Fort G, Lambert-Lacroix S. Classification using partial least squares with penalized logistic regression. Bioinformatics, 2005, 21: 1104-1111.
45. Feng C J, Yu A G, Unnati K, et al. Threefold vs fivefold cross validation in one-hidden-layer and two-hidden-layer predictive neural network modeling of machining surface roughness data. J Manuf syst, 2005, 24: 93-105.
46. Campbell G P, Curran J M, Miskelly G M, et al. Compositional data analysis for elemental data in forensic science. Forensic Sci Int, 2009, 81-90.
47. Marchese A, Beischlag T V, Nguyen T, et al. Two gene duplication events in the human and primate dopamine D5 receptor gene family. Gene, 1995, 154: 153-158.
48. Nicholson B J. On the F-distribution for calculating Bayes credible intervals for fraction nonconforming. IEEE Tran Reliab, 1985, 8: 227-228.
49. Harper W L, Hooker C A, Harper W L, et al. Foundations of probability theory, statistical inference, and statistical theories. Studia Logica, 1978, 37: 213-219.
50. Dettling M, Buhlmann P. Finding predictive gene groups from microarray data. J Mult Anal, 2004, 90: 106-131.
51. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics, 2007, 23: 257-258.
52. Martin-Subero J I, Kreuz M, Bibikova M, et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood, 2009, 113: 2488-2497.
53. Storey J D, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA, 2003, 100: 9440-9445.
54. Scheid S, Spang R. Twilight: A bioconductor package for estimating the local false discovery rate. Bioinformatics, 2005, 21: 2921-2922.
55. Becker KG, Hosack D A, Dennis G, et al. PubMatrix: A tool for multiplex literature mining. BMC Bioinformatics, 2003, 4: 61.
56. Dudoit S, Fridlyand J. A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol, 2002, 3: RESEARCH0036.
57. Margolin A A, Nemenman I, Basso K, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinform, 2006, 7(Suppl 1): S7.
58. Clinton M, Graeve L, Dorry H, et al. Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ. Proc Natl Acad Sci USA, 1991, 88: 6608-6612.
59. Vareli K, Frangou-Lazaridis M, van der Kraan I, et al. Nuclear distribution of prothymosin alpha and parathymosin: Evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication. Exp Cell Res, 2000, 257: 152-161.
60. Lei M. The MCM complex: Its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets, 2005, 5: 365-380.
61. Tsitsilonis O E, Bekris E, Voutsas I F, et al. The prognostic value of alpha-thymosins in breast cancer. Anticancer Res, 1998 18: 1501-1508.
62. Fujiwaki R, Hata K, Nakayama K, et al. Thymidine kinase in epithelial ovarian cancer: Relationship with the other pyrimidine pathway enzymes. Int J Cancer, 2002, 99: 328-335.
63. Holleman A, den Boer M L, de Menezes R X, et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood, 2006, 107: 769-776.
64. Biswas S, Chytil A, Washington K, et al. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res, 2004, 64: 4687-4692.
65. Hoornaert I, Marynen P, Goris J, et al. MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene, 2003, 22: 7728-7736.
66. Ku J L, Yoon K A, Kim W H, et al. Establishment and characterization of four human pancreatic carcinoma cell lines Genetic alterations in the TGFBR2 gene but not in the MADH4 gene. Cell Tissue Res, 2002, 308: 205-214.
67. Grady W M, Markowitz S D. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet, 2002, 3: 101-128.
68. Guo J, Kleeff J, Li J, et al. Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene, 2004, 23: 71-81.
69. Shalgi R, Lieber D, Oren M, et al. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol, 2007, 3: e131.
70. Wu F, Zhu S, Ding Y, et al. microRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res, 2009, 15: 1550-1557.
71. Kozaki K, Imoto I, Mogi S, et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res, 2008, 68: 2094-2105.
72. Bonci D, Coppola V, Musumeci M, et al. The miR-15a/miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med, 2008, 14: 1271-1277.
73. Sorrentino A, Liu C G, Addario A, et al. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol, 2008, 111: 478-486.
74. Yu J, Wang F, Yang G H, et al. Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun, 2006, 349: 59-68.
75. Lui W O, Pourmand N, Patterson B K, et al. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res, 2007, 67: 6031-6043.
76. Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 2009, 28: 1385-1392.
77. Michael M Z, SM O C, van Holst Pellekaan N G, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res, 2003 1: 882-891.
78. Chen H C, Chen G H, Chen Y H, et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 2009, 100: 1002-1011.
79. Nasser M W, Datta J, Nuovo G, et al. Down-regulation of microRNA-1 (miR-1) in lung cancer Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem, 2008, 283: 33394-33405.
80. Datta J, Kutay H, Nasser M W, et al. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res, 2008, 68: 5049-5058.
81. Karwowska S, Zolla-Pazner S. Passive immunization for the treatment and prevention of HIV infection. Biotechnol Ther, 1991, 2: 31-48.
82. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull, 2006, 29: 903-906.
83. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 2004, 64: 3753-3756.
84. Schultz J, Lorenz P, Gross G, et al. microRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res, 2008, 18: 549-557.
85. Wang X, Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res, 2006, 34: 1646-1652.
86. Thomson J M, Newman M, Parker J S, et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev, 2006, 20: 2202-2207.
87. Kuhn D E, Martin M M, Feldman D S, et al. Experimental validation of miRNA targets. Methods, 2008, 44: 47-54.
88. Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol, 2008, 18: 79-88.